Compare XLO & IPWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | XLO | IPWR |
|---|---|---|
| Founded | 2016 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 39.4M | 42.1M |
| IPO Year | 2021 | 2013 |
| Metric | XLO | IPWR |
|---|---|---|
| Price | $8.41 | $3.81 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $28.00 | $10.75 |
| AVG Volume (30 Days) | 31.3K | ★ 115.8K |
| Earning Date | 05-14-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $43,766,000.00 | N/A |
| Revenue This Year | N/A | $2,603.56 |
| Revenue Next Year | $168.77 | $1,800.00 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 589.88 | N/A |
| 52 Week Low | $0.46 | $2.62 |
| 52 Week High | $9.25 | $6.90 |
| Indicator | XLO | IPWR |
|---|---|---|
| Relative Strength Index (RSI) | 69.92 | 63.79 |
| Support Level | $0.62 | $3.77 |
| Resistance Level | $9.22 | $4.02 |
| Average True Range (ATR) | 0.43 | 0.39 |
| MACD | -0.27 | 0.11 |
| Stochastic Oscillator | 29.47 | 76.55 |
Xilio Therapeutics Inc is a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effects of current I-O treatments. The company is using its proprietary platform to advance a pipeline of novel, tumor-activated clinical and preclinical I-O molecules that are designed to optimize the therapeutic index by localizing anti-tumor activity within the tumor microenvironment, including tumor-activated cytokines and antibodies and immune cell engagers.
Ideal Power Inc is engaged in the development of its broadly patented bidirectional power switches, creating efficient and ecofriendly energy control solutions for electric vehicles, electric vehicle charging, renewable energy, energy storage, UPS / data center, solid-state circuit breaker and other industrial and military applications. The company is focused on its patented Bidirectional, Bipolar Junction Transistor (B-TRAN) semiconductor technology. B-TRAN is a double-sided bidirectional AC switchable to deliver substantial performance improvements over conventional power semiconductors. The primary raw material used in the fabrication of B-TRAN devices is silicon wafers.